Crystal Adam
President, R&D
Crystal Adam has filed 12 SEC Form 4 filings (28 transaction rows) across 1 company, with disclosures dating back to 2026. 12 of those filings fall inside the rolling window. Most recent filing: Oct 5, 2026.
On the most recent filing, Crystal Adam is listed as President, R&D at Tango Therapeutics, Inc. Inside the rolling window, Crystal Adam reported no open-market purchases and 12 open-market sales totaling $7.0M in TNGX. The largest disclosed transaction in the window is a sale of 38,460 TNGX shares on Apr 15, 2026, worth $962K.
Companies traded
Other insiders at TNGX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$7.0M
reported sales (SEC code S)
Companies
1
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| TNGX | President, R&D | Sale | 27,000 | $661K | Oct 5 | SEC ↗ | |
| TNGX | President, R&D | Sale | 27,000 | $604K | Sep 3 | SEC ↗ | |
| TNGX | President, R&D | Sale | 27,000 | $736K | Aug 5 | SEC ↗ | |
| TNGX | President, R&D | Sale | 27,000 | $799K | Jul 2 | SEC ↗ | |
| TNGX | President, R&D | Sale | 27,000 | $618K | Jun 3 | SEC ↗ | |
| TNGX | President, R&D | Sale | 27,000 | $573K | May 5 | SEC ↗ | |
| TNGX | President, R&D | Sale | 38,460 | $962K | Apr 16 | SEC ↗ | |
| TNGX | President, R&D | Sale | 27,000 | $572K | Apr 2 | SEC ↗ | |
| TNGX | President, R&D | Sale | 12,000 | $241K | Mar 27 | SEC ↗ | |
| TNGX | President, R&D | Sale | 20,251 | $304K | Mar 9 | SEC ↗ | |
| TNGX | President, R&D | Sale | 54,345 | $694K | Feb 27 | SEC ↗ | |
| TNGX | President, R&D | Sale | 18,452 | $226K | Feb 4 | SEC ↗ |
Frequently asked questions
How many SEC Form 4 filings has Crystal Adam made?
Crystal Adam has filed 12 SEC Form 4 filings (28 transaction rows) across 1 company since 2026.
Which companies does Crystal Adam trade?
Crystal Adam has filed SEC Form 4 disclosures for 1 company, including TNGX.
When was Crystal Adam's most recent SEC Form 4 filing?
Crystal Adam's most recent SEC Form 4 filing on Tracefour is dated Oct 5, 2026.
What is Crystal Adam's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Crystal Adam is listed as President, R&D.
What is Crystal Adam's total buy and sell value in the current window?
Inside the rolling retention window, Crystal Adam bought $0 and sold $7.0M based on SEC Form 4 filings.
What was Crystal Adam's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 38,460 TNGX shares on 2026-04-15, worth $962K, per SEC Form 4 filings.